Medicare to Negotiate Lower Prices for Weight-Loss Drugs
Posted inDrugs (Pharmaceuticals) GLP-1 RAs (Drug) Health and Human Services Department Health Insurance and Managed Care Medicare Novo Nordisk A/S Obesity Ozempic (Drug) Prices (Fares, Fees and Rates) United States Politics and Government Weight

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
FDA Bans Red Dye 3 in Foods, Linking It to Cancer in Rats
Posted inCancer Color Consumer Protection Drugs (Pharmaceuticals) Dyes and Dyestuffs Environmental Working Group Food Food Additives Food and Drug Administration Food Contamination and Poisoning Rats Recalls and Bans of Products Regulation and Deregulation of Industry

FDA Bans Red Dye 3 in Foods, Linking It to Cancer in Rats

Consumer and food safety groups have long urged the agency to revoke the use of this dye and others. The F.D.A. says there still is no evidence it is a human carcinogenic.